© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement
The virtual lobby of USCHA
The U.S. Conference on HIV/AIDS Is Happening Right Now!
trophy with stars coming out
POZ Awards 2020: Vote for Your Favorite!
POZ October/November 2020 cover
Click Here for the Current Issue of POZ

COVID-19 More Severe for Some Minorities at Different Stages of the Disease

Black patients are more likely to require hospitalization, while Asian patients are at greater risk of dying in the hospital.

POZ Poll: Do you feel too much importance is placed on being undetectable?

The Rise of Telemedicine

The COVID-19 pandemic has turned virtual health from a niche service into a mainstay of modern medicine. But it’s not working for everyone.
Donald Trump

White House Bans Diversity Trainings About Race and Sex Bias

AIDS United opposes this executive order. We remain deeply concerned about its impact on ending the HIV epidemic.

Truvada Tied to Changes in Gut-Based Immunity

Researchers studied people taking Truvada as PrEP and plan to conduct similar research on newer antiretrovirals.

MUST read

Larry Kramer
Everything Larry Kramer
Novel coronavirus SARS-CoV-2
UPDATED: What People With HIV Need to Know About the New Coronavirus
The Truth About the 7,000
Mark S. King: I Wrote “The Truth About the 7,000.” Now What?
Listen Now: Signorile and King Discuss “The Truth About the 7,000”
#African American
#Latino
#Women
A black circular fabric patch with pink and black words inscribed “Dirty & Proud” centered over a pink triangle within the patch.

Of Dirt & Water

Trans Latina writer, artist and organizer Sebastián Castro Niculescu explores the elements in the November web gallery on Visual AIDS.
Remdesivir production.

Remdesivir for COVID-19 Shows No Survival Benefit in Large Study

None of the four drugs tested in WHO’s Solidarity study reduced mortality or duration of hospitalization.
A sample of the “I Can Give U” campaign

What Can People With HIV Give You?

Hint: It starts with three letters.

Experimental Antiretroviral Has Potential for Once-Weekly HIV Treatment

MK-8507, a long-acting NNRTI, will be tested in a weekly regimen with islatravir.

Switching HIV Regimen to Biktarvy Is Safe and Effective for the Long Term

Gilead Sciences presented findings from several studies of the single-tablet antiretroviral regimen at a recent scientific meeting.

Hot topics

Forums: Support and discussion
Blogs: The community speaks
POZ Stories: Get inspired
Magazine: Search the archives
HIV: The Basics
Recursos de VIH/SIDA en Español
AIDS Is Everyday
Ask POZ

Consider the Unintended Consequences on Patient Care

The Centers for Medicare & Medicaid Services should hit pause on a proposal.
Campaign images for #NLAAD2020

National Latinx AIDS Awareness Day 2020

The theme of this year’s #NLAAD is “Ending HIV Is at Your Fingertips.”

DC Bill Protects LGBT Seniors and Those With HIV. But There’s a Catch

Plus: An affordable housing community for LGBT seniors in Florida sets aside units for folks with HIV.
Novel coronavirus SARS-CoV-2

NIH Study Aims To Identify Promising COVID-19 Treatments for Larger Trials

The study asks whether certain approved therapies or late-stage investigational drugs show promise against COVID-19.
Advertisement
Newsfeed
Treatment News
Features
Opinions